Platelet-monocyte interaction in Mycobacterium tuberculosis infection

Area of Science:

• Immunology
• Infectious Diseases
• Hematology

Background:

• Platelets and platelet-leukocyte aggregation play crucial roles in immune responses.
• Understanding platelet-monocyte aggregation (PMA) in tuberculosis (TB) is vital for comprehending disease pathogenesis and immune modulation.

Purpose of the Study:

• To investigate the occurrence of PMA in pulmonary TB patients.
• To elucidate the underlying mechanisms of PMA in TB.
• To determine the consequences of PMA on cytokine responses during TB infection.

Main Methods:

• Cross-sectional study of 65 Tanzanian TB patients and 29 healthy controls.
• Flow cytometry to assess monocyte and platelet activation markers (CCR5, CD16, CD11b, P-selectin).
• In vitro whole blood assays with Mycobacterium tuberculosis (Mtb) and peripheral blood mononuclear cells (PBMCs) to analyze cytokine profiles (IL-1β, TNF-α, IL-6, IFN-γ, IL-10).

Main Results:

• TB patients exhibited significantly higher PMA compared to healthy controls.
• Increased PMA in TB was linked to elevated monocyte CCR5, CD16 expression, and PF4 levels.
• In vitro, Mtb activated monocytes but not platelets; PMA was independent of platelet-monocyte interaction.
• Platelets demonstrated an anti-inflammatory effect, reducing pro-inflammatory cytokines (IL-1β, TNF-α, IL-6, IFN-γ) and increasing IL-10 production in Mtb-stimulated PBMCs.

Conclusions:

• Elevated PMA in TB is primarily driven by monocyte activation, not platelet activation.
• Platelets may mitigate excessive tissue damage by modulating Mtb-induced leukocyte responses.
• However, platelets might also impair the production of essential protective cytokines like IFN-γ and TNF-α in TB patients.